Evolution of proton pump inhibitor prescribing from 2017 to 2021 at 14 secondary and tertiary hospitals in China：a multicentre cross-sectional study

OBJECTIVE: The objective of this study was to describe the trend in prescribing proton pump inhibitor (PPI) use and expenditure in both secondary and tertiary hospitals in China between 2017 and 2021. DESIGN: Multicentre cross-sectional survey. SETTING: China, 14 medical centres, January 2017 to Dec...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeng, Min, Li, Yuan, Chen, Tao, Zhang, Shengmin, Luo, Hongli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Gastroenterology and Hepatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10335495/
https://www.ncbi.nlm.nih.gov/pubmed/37400237
http://dx.doi.org/10.1136/bmjopen-2023-072793

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10335495/
https://www.ncbi.nlm.nih.gov/pubmed/37400237
http://dx.doi.org/10.1136/bmjopen-2023-072793

Ejemplares similares